Benefits and Risks of Menopausal HT Among Women 50-59

This report analyzes additional years of follow-up from the Women’s Health Initiative hormone therapy trials, with a focus on participants 50-59 years of age. Does the new data change recommendations?

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/947147
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started